Viewing Study NCT04899492



Ignite Creation Date: 2024-05-06 @ 4:10 PM
Last Modification Date: 2024-10-26 @ 2:05 PM
Study NCT ID: NCT04899492
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-12
First Post: 2021-05-19

Brief Title: Evaluation of Different Smoking Cessation Protocols Nicotine Replacement Motivational Interviewing MI Cognitive Behavioural Therapy CBT or Hypnotherapy in Cancer Patients Scheduled for Surgery
Sponsor: Institut Cancerologie de lOuest
Organization: Institut Cancerologie de lOuest

Study Overview

Official Title: Pilot Study in Cancer Patients Scheduled for Surgery Evaluating Different Smoking Cessation Protocols Nicotine Replacement Motivational Interviewing MI Cognitive Behavioural Therapy CBT or Hypnotherapy
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RESPIRE
Brief Summary: This trial offers support and assistance to patients wishing to quit smoking in order to increase the success rate of smoking cessation and all the benefits associated with it Patients will be monitored by a tobacco specialist and will be able to benefit from one or more therapies complementary to Nicotine Replacement Therapy NRT Motivational Interviewing MI Cognitive Behavioural Therapy CBT or Hypnotherapy
Detailed Description: The study RESPIRE is aiming to identify some interventions to be proposed as part of a smoking cessation programme for smokers with cancer requiring surgical treatment and wishing to stop smoking We aim to compare different smoking cessation methods in addition to the currently recommended treatments Nicotine Replacement Therapy NRT These procedures are Cognitive Behavioural Therapy CBT Motivational Interviewing MI or hypnotherapy in order to improve the success rate of smoking cessation in this specific population

All patients wishing to be supported to stop smoking will be randomized and will be followed by a tobacco specialist before and after surgery They will receive NRT for 12 months

Smoking assessment exhaled CO measurement questionnaires will be completed regularly to assess depression anxiety and quality of life during the 12 months

Patients randomized in group 2 will receive 1 to 3 MI Patients randomized in group 3 will receive 1 to 3 MI and 6 CBT sessions by a psychotherapist

Patients randomized in group 4 will receive 1 to 3 MI and at least 3 sessions oh hypnotherapy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None